| OSMYX | RAIIX | OSMYX / RAIIX | |
| Total Expense Ratio | 1.13 | 1.16 | 97% |
| Annual Report Gross Expense Ratio | 1.13 | 1.16 | 97% |
| Fund Existence | 20 years | 14 years | - |
| Gain YTD | 2.511 | 5.824 | 43% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 1000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.56B | 400M | 640% |
| Annual Yield % from dividends | 1.67 | 2.31 | 72% |
| Returns for 1 year | -3.46 | 29.86 | -12% |
| Returns for 3 years | -12.40 | 33.86 | -37% |
| Returns for 5 years | -31.66 | -1.24 | 2,559% |
| Returns for 10 years | 14.25 | 109.92 | 13% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| ISMVX | 12.13 | 0.10 | +0.83% |
| William Blair Small-Mid Cap Value I | |||
| JFCCX | 31.28 | 0.22 | +0.71% |
| JHancock Fundamental All Cap Core C | |||
| VCRQX | 15.42 | 0.09 | +0.59% |
| NYLI CBRE Global Infrastructure Class R6 | |||
| JFNAX | 79.57 | -0.11 | -0.14% |
| Janus Henderson Global Life Sciences A | |||
| ABYEX | 11.13 | -0.08 | -0.71% |
| AB Emerging Markets Multi-Asset Advisor | |||